Vitaduro Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 10 Year, 3 Months
- Last Filing with ROC 31 Mar 2018
- Revenue Growth 6.80%
- Profit Growth 144.35%
- Ebitda 54.36%
- Net Worth 7.32%
- Total Assets -13.59%
About Vitaduro Healthcare
Vitaduro Healthcare Private Limited (VHPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 November 2014 and has a history of Ten years and three months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Neha Arya, Nancy Ranjan, and Om Prakash serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51505MH2014PTC259553
- Company No.
259553
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Nov 2014
- Date of AGM
29 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Vitaduro Healthcare Private Limited offer?
Vitaduro Healthcare Private Limited offers a wide range of products and services, including Diagnostic Medical Imaging Equipment, Ultrasound Accessories.
Who are the key members and board of directors at Vitaduro Healthcare?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neha Arya  | Director | 22-Mar-2018 | Current |
| Nancy Ranjan | Director | 15-Nov-2016 | Current |
| Om Prakash | Director | 20-Nov-2014 | Current |
Financial Performance of Vitaduro Healthcare.
Vitaduro Healthcare Private Limited, for the financial year ended 2018, experienced modest growth in revenue, with a 6.8% increase. The company also saw a substantial improvement in profitability, with a 144.35% increase in profit. The company's net worth moved up by a moderate rise of 7.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vitaduro Healthcare?
In 2018, Vitaduro Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vitaduro Healthcare?
Unlock and access historical data on people associated with Vitaduro Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vitaduro Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vitaduro Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
